FDA Warns of Link Between Fosamprenavir and Myocardial Infarction
Links shared publicly online about this topic
FDA: Link between fosamprenavir and MI, dyslipidemia
theheart.org — “Fosamprenavir calcium is associated with an increased risk of MI and dyslipidemia in HIV-infected adults, according to the FDA.” View full resource at theheart.org
Most Recently Shared on December 8, 2009 at 6:11 pm By:
FDA warning: Increased MI, dyslipidemia with fosamprenavir http://bit.ly/5UVUcD #heartwire
FDA Alert: Lexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter
drugs.com — “FDA Alert: Lexiva (fosamprenavir calcium) - Dear Healthcare Professional Letter” View full resource at drugs.com
Most Recently Shared on December 4, 2009 at 7:44 pm By:
FDA Alert - GlaxoSmithKline and FDA Inform Healthcare Professionals of New Warnings for Lexiva (fosamprenavir) - http://bit.ly/8j4QC2
FDA warns of potential cardiovascular risk with Lexiva in HIV-infected patients - MPR
empr.com — “The FDA and GlaxoSmithKline have notified healthcare professionals of a potential association between Lexiva (fosamprenavir calcium) and myocardial infarction and dyslipidemia in HIV-infected adults.” View full resource at empr.com
Most Recently Shared on December 3, 2009 at 10:09 pm By:
MPR News: FDA warns of potential cardiovascular risk with Lexiva in HIV-infected patients: The FDA and GlaxoSmithKl... http://bit.ly/6eyGj4
FDA to parents: Don't toss ADHD drugs yet - Kids and parenting- msnbc.com
msnbc.msn.com — “The FDA is urging parents to keep their children on attention deficit drugs like Ritalin and Adderall, despite new evidence that the stimulants can increase the risk of sudden death.” View full resource at msnbc.msn.com
Most Recently Shared on June 15, 2009 at 5:16 pm By:
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Drugs.com
Keeping you up to date with the latest medication news, FDA Medwatch alerts and new drug approvals.
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
Advertisement

